Bill Illis
Bill has over 30 years of industry experience in R&D spanning domains of cancer epidemiology, health care cost/utilization research preclinical safety, clinical development and regulatory fffairs including functional leadership in data management, programming, statistics, data standards and governance, information technology and operations.
Bill is currently Executive Director, Technology & Statistical Computing, in the Advanced Quantitative Sciences function of Global Drug Development at Novartis, based in East Hanover, NJ. He is responsible for developing and implementing the analytics technology strategy focused on end-to-end clinical data flows, systems and processes and overseeing a portfolio of analytics capability development. For the past several years he has also served as the industry workstream lead for the Digital Data Flow initiative at the pharmaceutical industry consortium TransCelerate Biopharma working in close collaboration with CDISC developing USDM data standard and digital protocol interoperability solutions.
Prior to Novartis Bill worked at Dun & Bradstreet on the acquisition and analysis of health care cost and utilization data, and at the Michigan Cancer Foundation supporting National Institutes of Health, SEER Program and the production of population-based cancer incidence statistics and associated research. He holds a Master of Public Health degree from the University of Michigan.